Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers

A Juan, MM Noblejas-López, I Bravo, M Arenas-Moreira, …

Cancers. 2022, 14 (18), 4474